Know Cancer

or
forgot password

    • cancer clinical trials in lawton, OK

    • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Cleo Craig Cancer Research Clinic
    Lawton, Oklahoma 73505
    Breast Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Cleo Craig Cancer Research Clinic
    Lawton, Oklahoma 73505
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Cleo Craig Cancer Research Clinic
    Lawton, Oklahoma 73505
    Esophageal Cancer, Gastric Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Cleo Craig Cancer Research Clinic
    Lawton, Oklahoma 73505
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Cancer Centers of Southwest Oklahoma Research - Lawton
    Lawton, Oklahoma 73505
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Cancer Centers of Southwest Oklahoma, LLC - Lawton
    Lawton, Oklahoma 73505
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Cancer Centers of Southwest Oklahoma
    Lawton, Oklahoma 73505
    Breast Cancer
    Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer
    Cancer Centers of Southwest Oklahoma
    Lawton, Oklahoma 73505
    Breast Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Cancer Centers of Southwest Oklahoma, LLC - Lawton
    Lawton, Oklahoma 73505
    Lung Cancer
    Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
    Cancer Centers of Southwest Oklahoma
    Lawton, Oklahoma 73505
    Lymphoma
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Cancer Centers of Southwest Oklahoma
    Lawton, Oklahoma 73505
    Non-Small-Cell Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Cancer Centers of Southwest Oklahoma, LLC - Lawton
    Lawton, Oklahoma 73505
    Kidney Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Cancer Centers of Southwest Oklahoma
    Lawton, Oklahoma 73505
    Advanced Prostate Cancer, Prostatic Neoplasms
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Cleo Craig Cancer Research Clinic
    Lawton, Oklahoma 73505
    Melanoma (Skin)
    Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
    Cancer Centers of Southwest Oklahoma Research
    Lawton, Oklahoma
    Breast Neoplasms, Neoplasm Metastasis
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Cleo Craig Memorial Cancer Ctr. & Research Clinic
    Lawton, Oklahoma 73505
    Non-Small Cell Lung Cancer